Opinion|Videos|April 25, 2025
Closing Perspectives
Experts discuss how to evaluate the cost-effectiveness of continuous glucose monitoring (CGM) compared to traditional monitoring, considering both clinical and quality outcomes, and what combination of economic and quality data would most effectively support broader CGM adoption across health systems and payer organizations.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How do you evaluate the cost-effectiveness of CGM compared to traditional monitoring when considering both clinical and quality outcomes?
- What: combination of economic and quality data would most effectively support broader CGM adoption across health systems and payer organizations?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule
2
Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations
3
New Dermatologic Therapies Make Waves at Maui Derm 2026
4
Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust
5
